M. M. O’Neill

Mitigation of Off-Target Adrenergic Binding and Effects on Cardiovascular Function in the Discovery of Novel Ribosomal S6 Kinase 2 Inhibitors

J. Madwed, R. Fryer, M. Kashem, 2012, Journal of Pharmacology and Experimental Therapeutics.

Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies.

R. Rothlein, E. Mainolfi, M. M. O'Neill, 1988, Journal of immunology.

Novel Strategies for Plant-Derived Anticancer Agents

J. Lewis, C. Beecher, D. D. Brown, 1995 .

Glucose-regulated insulin production from genetically engineered human non-beta cells.

R. Barton, W. Osborne, R. D. Schneiderman, 2007, Life sciences.

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.

M. Kashem, R. Snow, S. Jakes, 2008, Biochemical and biophysical research communications.

The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury

B. Berk, P. Brookes, Scott M Macdonnell, 2016, Journal of cardiovascular pharmacology and therapeutics.

Indole RSK inhibitors. Part 1: discovery and initial SAR.

J. Madwed, M. Kashem, R. Snow, 2012, Bioorganic & medicinal chemistry letters.